Advances in the structural understanding of Vif proteins

被引：41

作者：

Barraud, Pierre

Paillart, Jean-Christophe ^{[2
]}

Marquet, Roland ^{[2
]}

Tisne, Carine ^{[1
]}

机构：

[1] Univ Paris 05, Lab Cristallog, CNRS, UMR 8015, F-75006 Paris, France

[2] Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, Strasbourg, France

来源：

CURRENT HIV RESEARCH | 2008年 / 6卷 / 02期

关键词：

Vif protein; APOBEC3G; Cullin5; elongin; reverse transcription; RNA;

D O I：

10.2174/157016208783885056

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The multidomain HIV-1 Vif protein recruits several cellular partners to achieve neutralization of the antiviral activity of APOBEC3 proteins. Vif neutralizes APOBEC3G and APOBEC3F predominantly by forming an E3 ubiquitin ligase with Cullin5, ElonginB and ElonginC that targets these proteins for degradation by the ubiquitin-proteasome pathway. Vif associates with the Cullin5-ElonginB-ElonginC complex by binding directly to ElonginC via its SOCS-box motif and to Cullin5 via hydrophobic residues within a zinc-binding region formed by a conserved HCCH motif. The HIV-1 Vif-Cullin5-ElonginBC complex is then able to ubiquitinate the APOBEC3G factor bound to Vif by its N-terminal domain. In this review, we summarize the current knowledge about the structural determinants of Vif that allow it to interact with cellular and viral partners.

引用

页码：91 / 99

页数：9

共 88 条

[71]

Strebel K, 2007, ADV PHARMACOL, V55, P199, DOI 10.1016/S1054-3589(07)55006-4

[72] Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F [J].